| Date Filed | Type | Description |
| 10/02/2023 |
4
| Vakiener Victoria (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Sold 1,550 shares
@ $26.33, valued at
$40.8k
|
|
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Vakiener Victoria (Director) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 60,000 options to buy
@ $1.39, valued at
$83.4k
|
|
| 01/11/2023 |
4
| Vakiener Victoria (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 1,764 shares
@ $0
Granted 7,867 shares
@ $0
Granted 4,593 options to buy
@ $33.03, valued at
$151.7k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2021 |
4
| Vakiener Victoria (Chief Commercial Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 817 shares
@ $11.21, valued at
$9.2k
|
|
| 02/02/2021 |
4
| Vakiener Victoria (Chief Commercial Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 25,520 shares
@ $0
Granted 121,754 options to buy
@ $11.02, valued at
$1.3M
|
|
| 01/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 09/28/2020 |
3
| Vakiener Victoria (Chief Commercial Officer) has filed a Form 3 on Epizyme, Inc. |